Skip to main content

AMD stock forecast 2025: Q2 is expected to perform strongly

AMD

Before the US stock market on July 19, US technology stocks continued their decline last Friday, and AMD's stock price also continued to fall.  AMD will announce the results of the second quarter of 2021 on July 27. The market expects this performance to be strong, so this round of decline may be a great opportunity to buy the stock.


 financial indicator


 Due to the strong market demand for CPU and graphics cards in 2021, AMD’s revenue is expected to exceed the maximum value of the financial guidance. AMD’s C&G business is expected to grow the most because higher-priced AMD Ryzen and high-end AMD Radeon sales continue to increase.


 In terms of gross profit margin, the market expects AMD's gross profit margin in Q2 2021 will increase by 47% year-on-year.  If the average selling prices of CPUs and GPUs continue to rise in Q2 of 2021, and the ASPs of CPUs and GPUs will increase in Q1 of 2021, the gross profit margin may also increase by 48%.


 CPU market share


 With a large number of customers adopting AMD’s processors, AMD’s market share continues to grow, compared to Intel’s decline.  Since AMD launched the first generation of AMD Ryzen, AMD’s CPU market share has doubled, and it is expected that AMD’s CPU market share in Q2 2021 may also increase.


 Free cash flow


 AMD's free cash flow is also growing rapidly.  Assuming that AMD’s free cash flow in Q2 in 2021 is the same as in Q1 in 2021, the free cash flow in Q2 is US$895 million, an increase of 8% from the previous quarter.  However, the increase in EPYC revenue/average selling price indicates that AMD’s cash flow has the potential to continue to grow. Therefore, AMD’s free cash flow is expected to achieve 30% year-on-year growth in 2022.


 Based on the strong growth momentum of the company's game business and corporate revenue business, it is expected to achieve a revenue of 17 billion US dollars in 2022 and a 30% year-on-year free cash flow growth. AMD's free cash flow may reach 5.1 billion US dollars.


 Valuation


 Relative to expected revenue and profit growth, AMD's valuation is at a relatively low level.  Thanks to the strong revenue growth of AMD EPYC and AMD Ryzen, AMD’s quarterly revenue has increased by 6-8%, and total revenue is expected to grow by approximately 50% in fiscal 2021.  AMD has a market-sales ratio of 6.04 and a price-earnings ratio of 31.7, both of which are far lower than NVIDIA.


 Risk


 AMD's rise is also accompanied by many risks.  As semiconductor companies increase chip production, supply shortages will no longer be a bottleneck. By then, the ASP of CPUs and GPUs may decline, and AMD's profit pressure will increase in this case.  If AMD's gross profit margin falls below 40%, its free cash flow will also decline, and its stock price may fall further.


 However, it is expected that the "no shortage of cores" will not happen until the end of 2022.  Before this, the declining gross profit margin was an early warning signal for semiconductor companies, because it could mean that AMD's stock yields are falling.


to sum up


 AMD is expected to announce a better-than-expected 2021 Q2 financial report.  Under the premise that ASP remains strong in the quarter, revenue may exceed financial guidance, gross margin may even be higher than 47%, and free cash flow will be slightly less than 900 million US dollars.


 By 2022, AMD’s annual free cash flow will reach at least $5 billion.  Compared with Nvidia, AMD's valuation will be more impressive.

Labels:

Comments

Post a Comment

Popular posts from this blog

Moderna stock forecast 2025： MRNA is worth buying for 5 reasons

Moderna was founded in 2009 and was established in Cambridge, Massachusetts, USA. Its main business is genetic engineering and focuses on the research and development of mRNA-derived drugs. The full name of mRNA is messenger RNA, pre-messenger RNA, a kind of immature single-stranded messenger ribonucleic acid, once it is completely processed, it is called "mature messenger RNA", or "mRNA". These drugs use mRNA as a treatment method and use mRNA as the basis to inject the developed synthetic mRNA into the patient's body so that the patient's own cells can obtain the ability to treat themselves. At present, the new crown vaccine being researched and developed by Moderna has an effective rate of 94.5%, so it has become one of the vaccines that are sold in large quantities all over the world. Cambridge, Massachusetts, is not only home to Harvard University but also a world-renowned hot spot for modern biomedicine. Despite such a "gorgeous background", ...
Post a Comment
Read more

NIO vs LI vs XPEV stock： Q1 financial report analysis

Q1 financial report analysis： NIO vs LI vs XPEV stock  In the financial report, the most striking thing is the delivery volume.  Comprehensive data shows that the NIO Q1 delivery volume exceeded 20,000 for the first time and continued to lead.  Beginning in 2021, NIO set a record of 20,060 deliveries in the first quarter, an increase of 422.7% year-on-year.  All aspects of XPEV can be described as "stable".  The delivery of LI decreased by 13.03% month-on-month, making it the only company among the top three automakers that had a negative growth rate from the previous month.    At the same time, the financial report showed that after achieving profit in the previous quarter, LI Q1 turned into a loss.  The net loss reached 360 million yuan, an increase of 366.9% year-on-year.  It is not difficult to see that the gap between LI Auto and the other two companies has not narrowed.  At the same time, in the car-making boom, the market's v...
Post a Comment
Read more

C3.ai stock forecast 2025: Is it time to buy now?

  Few emerging technologies are as exciting as artificial intelligence. We have witnessed its ability to be applied in new ways, from quickly analyzing large amounts of data to improve the efficiency of hardware and software. C3.ai(AI) is one of the only companies in the world that develop artificial intelligence into independent services. In short, artificial intelligence is its entire business.  Investors avoided such stocks this year because large technology companies began to engage in artificial intelligence projects, raising concerns about increased competitive threats.  However, C3.ai continued to increase revenue, narrowed its losses, and added 82% of its customers in the fourth quarter of fiscal 2021. Therefore, the stock price has fallen about 60% so far this year, which may be a huge opportunity for those who want to get involved in this field.  A unique business case  Imagine that if a company needs to develop its own artificial intelligence, sim...
Post a Comment
Read more